Cambridge Ophthalmological Symposium
3rd – 5th September 2008
Transplantation
Provisional Programme
|
| Ocular immune privilege |
Andrew Taylor,
Boston |
| Natural barriers to retinal transplantation |
James Fawcett , Cambridge |
| Immunological mechanisms of corneal allograft rejection: implications for developing new therapies |
Douglas Coster, Adelaide |
| Improving survival and adherence of retinal cell lines
|
Peter Coffey, London |
| Prospects for genetic modulation of corneal graft survival |
Keryn Williams, Adelaide |
| Prospects for gene replacement therapy in human retinal disease |
Anthony Moore, London |
| Culturing RPE cells for transplantation
|
Carl Sheridan, Liverpool |
| Olfactory cell transplantation to the eye |
Geoffrey Raisman, London |
| Ocular hypotension: would ciliary body transplantation help? |
Peter Watson, Cambridge |
| Risks and prevention of prion transfer Bristol |
John Armitage, Bristol |
| Indications and techniques for corneal rotational autografts |
John Dart, London |
| Overview of ocular stem cells |
Eric Mayer , Bristol |
| Limbal stem cell transplantation |
Scheffer Tseng, Miami |
| Use of amniotic membrane |
Harminda Dua, Nottingham |
| Antibody-based immunosuppressive agents for corneal transplantation |
Michael Thiel, Luzern |
| Surgical rehabilitation of patients with prior severe ocular burns |
Stephen Tuft, London |
| Surgical management of patients with combined glaucoma and corneal transplant surgery |
Richard Lee, Miami |
| Transplantation prospects for inner retinal disease |
Keith Martin, Cambridge |
| Transplantation prospects for outer retinal disease |
Robert MacLaren, London |
| Keratoprostheses and artificial corneas |
May Griffith, Ottowa |
| Endothelial keratoplasty |
Gerrit Melles, Rotterdam |
| Current and future prospects for optoelectronic retinal prostheses
|
J Dowling, Brisbane |
| |
|